DeepMind is an artificial intelligence lab in London that creates what are known as general purpose self-learning algorithms. The company, acquired by Google in 2014 for a reported 400 million, is best-known for creating software „agents" that have mastered games like…

DeepMind is an artificial intelligence lab in London that creates what are known as general purpose self-learning algorithms. The company, acquired by Google in 2014 for a reported 400 million, is best-known for creating software "agents" that have mastered games like Go and Space Invaders but it also wants to apply its technology to healthcare. Mustafa Suleyman, DeepMind cofounder and head of DeepMind Health, gave a talk at the King's Fund in London this week where he explained how the company is working with the NHS and what kind of benefits patients can expect to see in the long run. The company operates independently of Google and creates software that can think for itself. In order to create this kind of AI software, DeepMind draws on huge data sets that can help to teach DeepMind's AI how to perform certain tasks.

"Our research with DeepMind has the potential to revolutionise the way professionals carry out eye tests and could lead to earlier detection and treatment of common eye diseases such as age-related macular degeneration," said Professor Sir Peng Tee Kaw, the head of Moorfields' ophthalmology research centre. DeepMind, which Google paid 400 million to acquire two years ago, hopes to use artificial intelligence to advance medical and climate research after its software defeated the world champion at the ancient Chinese board game Go.

An artifical intelligence (AI) diagnosis for eye disease is becoming more likely with Google's DeepMind. Computerworld reports that Google's AI business unit is using patient data from a U.K. hospital in an effort to teach computers how to detect early warning signs of sight loss. Although some hurdles currently exist in implementing health care AI, initiatives like this have potential to transform the future of patient care. The traditional way doctors look for certain eye diseases is to examine an area of the eye called the fundus by either using an ophthalmoscope or by taking a digital fundus scan. Optical coherence tomography is another diagnostic technique that uses a noninvasive, three-dimensional scan of the retina, according to Computerworld.

If you think Google has a controversial reputation at this point in its business evolution, buckle up because things are really stepping up a gear -- as its machine learning DeepMind division pushes for access to publicly funded healthcare data.

Want to watch this again later? Need to report the video? This feature is not available right now.

Google DeepMind is training its artificial intelligence software to detect early signs of eye diseases. It's aimed at detecting two diseases -- age-related macular degeneration and diabetic retinopathy. The latter can lead to blindness if not detected early. DeepMind is analyzing about 1 million eye scans to develop an algorithm that can catch early warning signs of the conditions. "If you have an OCT scan done, a machine learning algorithm will be able to tell you if it's urgent versus something that's not so urgent. The company has caught flak from privacy critics in the past.

Google's artificial intelligence division, DeepMind, has teamed up with a hospital in England on a research project that could lead to detecting vision loss and other eye problems sooner, Popular Mechanics writes. The article says the project calls for giving DeepMind's computer more than a million anonymous eye scans to let it learn patterns and make predictions. DeepMind's idea is to train AI to detect early signs of age-related macular degeneration as well as vision loss related to diabetes.

A few years ago, the general public thought artificial intelligence (AI) was but a futuristic technology exclusive to science fiction. That is until DeepMind was created in 2010, an artificial intelligence (AI) company that was later bought by Google in 2014, and is now making big strides in the industry. DeepMind currently boasts fully functioning artificial agents capable of doing human tasks like learning how to play video games as well as performing similar cognitive functions like accessing key pieces of information from a short-term memory. It sounds surreal, like something out of an Isaac Asimov novel. These artificial agents, or programs, are using what's called reinforcement learning (RL).

Google and the U.K.'s government health service have partnered to study whether computers can be trained to spot degenerative eye problems early enough to prevent blindness. Google DeepMind, the London-based artificial intelligence unit owned by Alphabet, announced a research partnership today with the National Health Service to gain access to a million anonymous eye scans. DeepMind will use the data to train its computers to identify eye defects. The aim is to give doctors a digital tool that can read an eye-scan test and recognize problems faster. Earlier detection of eye disorders related to diabetes and age-related macular degeneration could allow doctors to prevent loss of vision in many people, according to a statement by DeepMind Tuesday announcing the project with the Moorfields Eye Hospital NHS Foundation Trust.